Renaissance Technologies (RenTech)'s OKUR Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 358,738 shares of OnKure Therapeutics, Inc. (OKUR) worth $1.64 M, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in OKUR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 129,900 shares. Largest reduction occurred in Q2 2026, reducing 18,512 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s OnKure Therapeutics (OKUR) Holding Value Over Time
Track share changes against reported price movement
Quarterly OnKure Therapeutics (OKUR) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -18,512 | Reduce 4.91% | 358,738 | $4.56 |
| Q1 2026 | +129,900 | Add 52.52% | 377,250 | $4.14 |
| Q4 2025 | +71,600 | Add 40.74% | 247,350 | $2.90 |
| Q3 2025 | +53,114 | Add 43.31% | 175,750 | $2.75 |
| Q2 2025 | +80,773 | Add 192.95% | 122,636 | $2.39 |
| Q1 2025 | -5,587 | Reduce 11.77% | 41,863 | $4.30 |
| Q4 2024 | +47,450 | New Buy | 47,450 | $8.60 |
Renaissance Technologies (RenTech)'s OnKure Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased OnKure Therapeutics, Inc. (OKUR) in Q4 2024, acquiring 47,450 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held OnKure Therapeutics, Inc. (OKUR) for 7 quarters since Q4 2024.
Renaissance Technologies (RenTech)'s largest addition to OnKure Therapeutics, Inc. (OKUR) was in Q1 2026, adding 377,250 shares worth $1.56 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 358,738 shares of OnKure Therapeutics, Inc. (OKUR), valued at approximately $1.64 M.
As of the Q2 2026 filing, OnKure Therapeutics, Inc. (OKUR) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in OnKure Therapeutics, Inc. (OKUR) was 377,250 shares, as reported at the end of Q1 2026.